References 1. Co DO, Hogan LH, Kim SI, Sandor M (2004) Mycobacterial granulomas: keys to a long-lasting host-pathogen relationship. Clin Immunol 113: 130–136. 2. Saunders BM, Britton WJ (2007) Life and death in the granuloma: immunopathology of tuberculosis. Immunol Cell Biol 85: 103–111. 3. Toussirot E, Wendling D (2004) The use of TNF-alpha blocking agents in rheumatoid arthritis: an overview. Expert Opin Pharmacother 5: 581–594. 4. Havlir DV, Barnes PF (1999) Tuberculosis in patients with human immuno- deficiency virus infection. N Engl J Med 340: 367–373. 5. Volkman HE, Clay H, Beery D, Chang JC, Sherman DR, et al. (2004) Tuberculous granuloma formation is enhanced by a mycobacterium virulence determinant. PLoS Biol 2: e367. 6. Ernst JD, Trevejo-Nunez G, Banaiee N (2007) Genomics and the evolution, pathogenesis, and diagnosis of tuberculosis. J Clin Invest 117: 1738–1745. 7. Hingley-Wilson SM, Sambandamurthy VK, Jacobs WR, Jr. (2003) Survival perspectives from the world’s most successful pathogen, Mycobacterium tuberculosis. Nat Immunol 4: 949–955. 8. Davis JM, Ramakrishnan L (2009) The role of the granuloma in expansion and dissemination of early tuberculous infection. Cell 136: 37–49. 9. Cosma CL, Humbert O, Ramakrishnan L (2004) Superinfecting mycobacteria home to established tuberculous granulomas. Nat Immunol 5: 828–835. 10. Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392: 245–252. 11. Schreiber HA, Sandor M (2009) The role of dendritic cells in mycobacterium- induced granulomas. Immunol Lett. 12. Jiao X, Lo-Man R, Guermonprez P, Fiette L, Deriaud E, et al. (2002) Dendritic cells are host cells for mycobacteria in vivo that trigger innate and acquired immunity. J Immunol 168: 1294–1301. 13. Reljic R, Di Sano C, Crawford C, Dieli F, Challacombe S, et al. (2005) Time course of mycobacterial infection of dendritic cells in the lungs of intranasally infected mice. Tuberculosis (Edinb) 85: 81–88. 14. Humphreys IR, Stewart GR, Turner DJ, Patel J, Karamanou D, et al. (2006) A role for dendritic cells in the dissemination of mycobacterial infection. Microbes Infect 8: 1339–1346. 15. Wolf AJ, Linas B, Trevejo-Nunez GJ, Kincaid E, Tamura T, et al. (2007) Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. J Immunol 179: 2509–2519. 16. Uehira K, Amakawa R, Ito T, Tajima K, Naitoh S, et al. (2002) Dendritic cells are decreased in blood and accumulated in granuloma in tuberculosis. Clin Immunol 105: 296–303. 17. Egen JG, Rothfuchs AG, Feng CG, Winter N, Sher A, et al. (2008) Macrophage and T cell dynamics during the development and disintegration of mycobacterial granulomas. Immunity 28: 271–284. 18. Rhoades ER, Frank AA, Orme IM (1997) Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. Tuber Lung Dis 78: 57–66. 19. Flynn JL (2006) Lessons from experimental Mycobacterium tuberculosis infections. Microbes Infect 8: 1179–1188. 20. Emile JF, Patey N, Altare F, Lamhamedi S, Jouanguy E, et al. (1997) Correlation of granuloma structure with clinical outcome defines two types of idiopathic disseminated BCG infection. J Pathol 181: 25–30. 21. Roche PW, Triccas JA, Winter N (1995) BCG vaccination against tuberculosis: past disappointments and future hopes. Trends Microbiol 3: 397–401. 22. Trunz BB, Fine P, Dye C (2006) Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 367: 1173–1180. 23. Ojo O, Sheehan S, Corcoran GD, Okker M, Gover K, et al. (2008) Mycobacterium bovis strains causing smear-positive human tuberculosis, Southwest Ireland. Emerg Infect Dis 14: 1931–1934. 24. Hlavsa MC, Moonan PK, Cowan LS, Navin TR, Kammerer JS, et al. (2008) Human tuberculosis due to Mycobacterium bovis in the United States, 1995- 2005. Clin Infect Dis 47: 168–175. 25. Etchechoury I, Valencia GE, Morcillo N, Sequeira MD, Imperiale B, et al. (2009) Molecular Typing of Mycobacterium bovis Isolates in Argentina: First Description of a Person-to-Person Transmission Case. Zoonoses Public Health. 26. Rodwell TC, Moore M, Moser KS, Brodine SK, Strathdee SA (2008) Tuberculosis from Mycobacterium bovis in binational communities, United States. Emerg Infect Dis 14: 909–916. 27. Grange JM, Daborn C, Cosivi O (1994) HIV-related tuberculosis due to Mycobacterium bovis. Eur Respir J 7: 1564–1566. 28. Sunder S, Lanotte P, Godreuil S, Martin C, Boschiroli ML, et al. (2009) Human- to-human transmission of tuberculosis caused by Mycobacterium bovis in immunocompetent patients. J Clin Microbiol 47: 1249–1251. 29. Hogan LH, Macvilay K, Barger B, Co D, Malkovska I, et al. (2001) Mycobacterium bovis strain bacillus Calmette-Guerin-induced liver granulomas contain a diverse TCR repertoire, but a monoclonal T cell population is sufficient for protective granuloma formation. J Immunol 166: 6367–6375. 30. Leon B, Lopez-Bravo M, Ardavin C (2005) Monocyte-derived dendritic cells. Semin Immunol 17: 313–318. 31. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, et al. (2010) Development of monocytes, macrophages, and dendritic cells. Science 327: 656–661. Dendritic Cells in Granulomas 32. Ulrichs T, Kaufmann SH (2006) New insights into the function of granulomas in human tuberculosis. J Pathol 208: 261–269. 33. Tsai MC, Chakravarty S, Zhu G, Xu J, Tanaka K, et al. (2006) Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension. Cell Microbiol 8: 218–232. 34. Lindquist RL, Shakhar G, Dudziak D, Wardemann H, Eisenreich T, et al. (2004) Visualizing dendritic cell networks in vivo. Nat Immunol 5: 1243–1250. 35. Bodnar KA, Serbina NV, Flynn JL (2001) Fate of Mycobacterium tuberculosis within murine dendritic cells. Infect Immun 69: 800–809. 36. Mohrs K, Wakil AE, Killeen N, Locksley RM, Mohrs M (2005) A two-step process for cytokine production revealed by IL-4 dual-reporter mice. Immunity 23: 419–429. 37. Brown JA, Dorfman DM, Ma FR, Sullivan EL, Munoz O, et al. (2003) Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J Immunol 170: 1257–1266. 38. Cai G, Karni A, Oliveira EM, Weiner HL, Hafler DA, et al. (2004) PD-1 ligands, negative regulators for activation of naive, memory, and recently activated human CD4+ T cells. Cell Immunol 230: 89–98. 39. Gu T, Zhu YB, Chen C, Li M, Chen YJ, et al. (2008) Fine-tuned expression of programmed death 1 ligands in mature dendritic cells stimulated by CD40 ligand is critical for the induction of an efficient tumor specific immune response. Cell Mol Immunol 5: 33–39. 40. Jurado JO, Alvarez IB, Pasquinelli V, Martinez GJ, Quiroga MF, et al. (2008) Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis. J Immunol 181: 116–125. 41. Latchman Y, Wood CR, Chernova T, Chaudhary D, Borde M, et al. (2001) PD- L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol 2: 261–268. 42. Orme IM (1987) The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis. J Immunol 138: 293–298. 43. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, et al. (1993) Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 178: 2243–2247. 44. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, et al. (1993) An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 178: 2249–2254. 45. Mogues T, Goodrich ME, Ryan L, LaCourse R, North RJ (2001) The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice. J Exp Med 193: 271–280. 46. Scanga CA, Mohan VP, Yu K, Joseph H, Tanaka K, et al. (2000) Depletion of CD4(+) T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2. J Exp Med 192: 347–358. 47. Casanova JL, Abel L (2002) Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol 20: 581–620. 48. North RJ, Jung YJ (2004) Immunity to tuberculosis. Annu Rev Immunol 22: 599–623. 49. Cooper AM (2009) Cell-mediated immune responses in tuberculosis. Annu Rev Immunol 27: 393–422. 50. Saunders PA, Hendrycks VR, Lidinsky WA, Woods ML (2005) PD-L2:PD-1 involvement in T cell proliferation, cytokine production, and integrin-mediated adhesion. Eur J Immunol 35: 3561–3569. 51. Keir ME, Francisco LM, Sharpe AH (2007) PD-1 and its ligands in T-cell immunity. Curr Opin Immunol 19: 309–314. 52. Chen L (2004) Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol 4: 336–347. 53. Loke P, Allison JP (2003) PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells. Proc Natl Acad Sci U S A 100: 5336–5341. 54. Yamazaki T, Akiba H, Iwai H, Matsuda H, Aoki M, et al. (2002) Expression of programmed death 1 ligands by murine T cells and APC. J Immunol 169: 5538–5545. 55. Alderson KL, Zhou Q, Berner V, Wilkins DE, Weiss JM, et al. (2008) Regulatory and conventional CD4+ T cells show differential effects correlating with PD-1 and B7-H1 expression after immunotherapy. J Immunol 180: 2981–2988. 56. Popov A, Schultze JL (2008) IDO-expressing regulatory dendritic cells in cancer and chronic infection. J Mol Med 86: 145–160. 57. Liu YJ, Soumelis V, Watanabe N, Ito T, Wang YH, et al. (2007) TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. Annu Rev Immunol 25: 193–219. 58. Natarajan K, Latchumanan VK, Singh B, Singh S, Sharma P (2003) Down- regulation of T helper 1 responses to mycobacterial antigens due to maturation of dendritic cells by 10-kDa mycobacterium tuberculosis secretory antigen. J Infect Dis 187: 914–928. 59. Motta A, Schmitz C, Rodrigues L, Ribeiro F, Teixeira C, et al. (2007) Mycobacterium tuberculosis heat-shock protein 70 impairs maturation of dendritic cells from bone marrow precursors, induces interleukin-10 production and inhibits T-cell proliferation in vitro. Immunology 121: 462–472. 60. Salam N, Gupta S, Sharma S, Pahujani S, Sinha A, et al. (2008) Protective immunity to Mycobacterium tuberculosis infection by chemokine and cytokine conditioned CFP-10 differentiated dendritic cells. PLoS One 3: e2869. PLoS ONE | www.plosone.org 13 July 2010 | Volume 5 | Issue 7 | e11453